$PHAS PhaseBio Pharmaceuticals Inc Insider Trading Week 42/2018

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in PhaseBio Pharmaceuticals Inc.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in PhaseBio Pharmaceuticals Inc in week 42/2018.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Klein Peter Justin	Director	Option Exercise	C	0.00	2,303	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Klein Peter Justin	Director	Option Exercise	S	0.00	3	0	2,303
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Klein Peter Justin	Director	Option Exercise	X	0.00	103	0	2,306
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Klein Peter Justin	Director	Option Exercise	X	0.12	103	12	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Klein Peter Justin	Director	Buy	C	0.00	2,303	0	2,303	0 to 2.3 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	C	0.00	1,124,301	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	C	0.00	437,706	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	S	0.00	4,349	0	437,706
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	X	0.00	181,190	0	442,055
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	X	0.12	181,190	21,743	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	C	0.00	3,279,627	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	S	0.00	1,177	0	3,279,627
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	X	0.00	49,030	0	3,280,804
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	X	0.12	49,030	5,884	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Buy	P	5.00	1,800,000	9,000,000	6,641,634	4.8 M to 6.6 M (+37.18 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Buy	C	0.00	4,841,634	0	4,841,634	0 to 4.8 M
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	30,334	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	6,413	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	63,688	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	22,452	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	4,746	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	47,140	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	165,395	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	34,968	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	347,250	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	56,874	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	12,025	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	C	0.00	119,408	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	S	0.00	113	0	22,452
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.00	4,690	0	22,565
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.12	4,690	563	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	S	0.00	24	0	4,746
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.00	991	0	4,770
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.12	991	119	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	S	0.00	237	0	47,140
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.00	9,847	0	47,377
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.12	9,847	1,182	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	S	0.00	81	0	165,395
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.00	3,359	0	165,476
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.12	3,359	403	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	S	0.00	18	0	34,968
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.00	710	0	34,986
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.12	710	85	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	S	0.00	170	0	347,250
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.00	7,053	0	347,420
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Option Exercise	M	0.12	7,053	846	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Buy	P	5.00	6,041	30,205	281,096	275.1 K to 281.1 K (+2.20 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Buy	C	0.00	275,055	0	275,055	0 to 275.1 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Buy	P	5.00	1,277	6,385	59,429	58.2 K to 59.4 K (+2.20 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Buy	C	0.00	58,152	0	58,152	0 to 58.2 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Buy	P	5.00	12,682	63,410	590,168	577.5 K to 590.2 K (+2.20 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	TUFTS LINDA	Director	Buy	C	0.00	577,486	0	577,486	0 to 577.5 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	226,061	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	24,709	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	272,107	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	40,420	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	13,558	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	149,320	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	94,874	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	1,044,764	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	13,609	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	174,699	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	4,846	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	3,862	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	42,530	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	52,690	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	994	0	40,420
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	41,414	0	41,414
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	41,414	4,970	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	104	0	13,558
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	4,309	0	13,662
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	4,309	517	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	1,139	0	149,320
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	47,458	0	150,459
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	47,458	5,695	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	42	0	94,874
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	1,731	0	94,916
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	1,731	208	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	458	0	1,044,764
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	19,061	0	1,045,222
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	19,061	2,287	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	P	5.00	150,000	750,000	416,481	266.5 K to 416.5 K (+56.29 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	266,481	0	266,481	0 to 266.5 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	4,846	0	4,846	0 to 4.8 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	P	5.00	12,487	62,435	163,099	150.6 K to 163.1 K (+8.29 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	150,612	0	150,612	0 to 150.6 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	P	5.00	137,513	687,565	1,820,933	1.7 M to 1.8 M (+8.17 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	1,683,420	0	1,683,420	0 to 1.7 M
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	52,690	0	52,690	0 to 52.7 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Mow Jonathan P	Chief Executive Off ...	Option Exercise	C	0.00	3,505	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Mow Jonathan P	Chief Executive Off ...	Option Exercise	C	0.00	310	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Mow Jonathan P	Chief Executive Off ...	Option Exercise	M	0.00	310	0	310
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Mow Jonathan P	Chief Executive Off ...	Option Exercise	M	0.12	310	37	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Mow Jonathan P	Chief Executive Off ...	Buy	C	0.00	3,505	0	48,699	45.2 K to 48.7 K (+7.76 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Mow Jonathan P	Chief Executive Off ...	Buy	C	0.00	310	0	310	0 to 310
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	226,061	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	24,709	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	272,107	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	40,420	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	13,558	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	149,320	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	94,874	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	1,044,764	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	13,609	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	174,699	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	4,846	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	3,862	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	42,530	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	C	0.00	52,690	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	S	0.00	994	0	40,420
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	X	0.00	41,414	0	41,414
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	X	0.12	41,414	4,970	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	S	0.00	104	0	13,558
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	X	0.00	4,309	0	13,662
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	X	0.12	4,309	517	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	S	0.00	1,139	0	149,320
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	X	0.00	47,458	0	150,459
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	X	0.12	47,458	5,695	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	S	0.00	42	0	94,874
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	X	0.00	1,731	0	94,916
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	X	0.12	1,731	208	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	S	0.00	458	0	1,044,764
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	X	0.00	19,061	0	1,045,222
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Option Exercise	X	0.12	19,061	2,287	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Buy	P	5.00	150,000	750,000	416,481	266.5 K to 416.5 K (+56.29 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Buy	C	0.00	266,481	0	266,481	0 to 266.5 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Buy	C	0.00	4,846	0	4,846	0 to 4.8 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Buy	P	5.00	12,487	62,435	163,099	150.6 K to 163.1 K (+8.29 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Buy	C	0.00	150,612	0	150,612	0 to 150.6 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Buy	P	5.00	137,513	687,565	1,820,933	1.7 M to 1.8 M (+8.17 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Buy	C	0.00	1,683,420	0	1,683,420	0 to 1.7 M
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Hatteras Venture Advisors III, ...	10% Owner	Buy	C	0.00	52,690	0	52,690	0 to 52.7 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	ASTRAZENECA PLC	10% Owner	Option Exercise	C	0.00	740,337	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	ASTRAZENECA PLC	10% Owner	Option Exercise	C	0.00	1,664,217	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	ASTRAZENECA PLC	10% Owner	Option Exercise	S	0.00	2,734	0	1,664,217
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	ASTRAZENECA PLC	10% Owner	Option Exercise	X	0.00	113,891	0	1,666,951
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	ASTRAZENECA PLC	10% Owner	Option Exercise	X	0.12	113,891	13,667	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	ASTRAZENECA PLC	10% Owner	Buy	P	5.00	600,000	3,000,000	3,004,554	2.4 M to 3 M (+24.95 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	ASTRAZENECA PLC	10% Owner	Buy	C	0.00	2,404,554	0	2,404,554	0 to 2.4 M
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Arnold Susan Elizabeth	VP, Preclinical and ...	Option Exercise	C	0.00	2,306	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Arnold Susan Elizabeth	VP, Preclinical and ...	Option Exercise	M	0.00	103	0	2,306
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Arnold Susan Elizabeth	VP, Preclinical and ...	Option Exercise	M	0.12	103	12	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Arnold Susan Elizabeth	VP, Preclinical and ...	Buy	C	0.00	2,306	0	2,306	0 to 2.3 K